Astellas Pharma reported JPY53.94B in EBITDA for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebitda Change
Astellas Pharma 4503:JP Y 53942M 59543M
Daiichi Sankyo 4568:JP Y 60453M 71607M
Eisai 4523:JP Y 64862M 61319M
Kyowa Hakko Kirin 4151:JP Y 19755M 131M
Otsuka Holdings 4578:JP Y 80272M 14755M
Shionogi 4507:JP Y 22540M 3511M
Sumitomo Dainippon 4506:JP Y 16577M 24865M